eNewsletters

    April 2021 FCDI NotebookIssue highlights:

    • Events:
      • Upcoming Meeting: Putting Science into Standards 2021 Edition: Organ-on-Chip
    • Publications:
      • Expression of HIV-1 Intron-Containing RNA in Microglia Induces Inflammatory Responses
      • Whole-Exome Sequencing and hiPSC Cardiomyocyte Models Identify MYRIP, TRAPPC11, and SLC27A6 of Potential Importance to Left Ventricular Hypertrophy in an African Ancestry Population
      • Applying the CiPA Approach to Evaluate Cardiac Proarrhythmia Risk of Some Antimalarials Used Off-label in the First Wave of COVID-19
    • Applications:
      • Plating iCell Cardiomyocytes2 on CELLvo™ Matrix Plus
      • Measuring Electrical Activity of iCell Motor Neurons on MEA with Optional iCell Astrocytes Co-culture

    Issue highlights:

    • News:
      • FUJIFILM Cellular Dynamics and Sana Biotechnology Announce License Agreement for the Development of iPSC-Derived Cell Therapies
      • Fujifilm plans to use the therapeutic cGMP-compliant iPSC manufacturing facility of FUJIFILM Cellular Dynamics, Inc. to expand the contract development and manufacturing of the therapeutic.
    • Events:
      • Register now for the AXXAM Bootcamp Webinar: Riding the Calcium Wave on iCell GlutaNeurons During HTS
    • Publications:
      • hiPSC-Derived Neurons Provide a Robust and Physiologically Relevant In Vitro Platform to Test Botulinum Neurotoxins
      • Relationships Between Constituents of Energy Drinks and Beating Parameters in Human Induced Pluripotent Stem Cell (iPSC)-Derived Cardiomyocytes
      • High-Content Analysis and Kinetic Image Cytometry Identify Toxic and Epigenotoxic Effects of HIV Antiretrovirals on Human iPSC-Neurons and Primary Neural Precursor Cells
      • Assessing the Angiogenic Efficacy of Pleiotrophin Released from Injectable Heparin-Alginate Gels

    FCDI Notebook February 2021Issue highlights:

    • News:
      • Missed the iForum™ 2021? View the Sessions Online
      • iCell Products in SARS-CoV-2 and COVID-19 Research: See Data on ACE-2 Expression and Cardiotoxicity Modeling
    • Events:
      • See upcoming poster presentations at AD/PD and SOT 2021
    • Publications:
      • iPSC-Derived Hepatocytes Generated from NASH Donors Provide a Valuable Platform for Disease Modeling and Drug Discovery
      • Electrophysiological Phenotype Characterization of Human iPSC-Derived Neuronal Cell Lines by Means of High-Density Microelectrode Arrays
      • Pluripotent Stem Cell-Derived Hepatocytes Phenotypic Screening Reveals Small Molecules Targeting the CDK2/4-C/EBPα/DGAT2 Pathway Preventing ER-Stress Induced Lipid Accumulation
    • Applications:
      • See the New Application Protocol: Measuring Cardiac Contractility with the Nanion FLEXcyte 96 System

    Issue highlights:

    • Upcoming Events:
      • Register now for the iForum™ 2021 Virtual User Group and see full agenda of speakers and talk titles
      • See the abstracts two poster presentations for SOT2021
    • New Publications:
      • Analysis of Reproducibility and Robustness of a Human Microfluidic Four-Cell Liver Acinus Microphysiology System (LAMPS)
      • A 3D Microfluidic Liver Model for High Throughput Compound Toxicity Screening in the OrganoPlate®

    Issue highlights:

    • Upcoming Events:
      • Register now for the iForum™ 2021 Virtual User Group and see the speakers confirmed for this event.
      • See the abstracts for a Alzheimer's disease modeling poster to be presented at SfN 2021
    • New Publications:
      • Soluble Factors Released by Dedifferentiated Fat Cells Reduce the Functional Activity of iPS Cell-Derived Cardiomyocytes
      • Rapid Hazard Characterization of Environmental Chemicals Using a Compendium of Human Cell Lines from Different Organs
    • Read how Century Therapeutics is addressing challenges in the manufacturing of iPSC-derived cell therapies through the use of their technology platform and partnership with FCDI.